Investigating Patient Characteristics of Intermediate Stage Hepatocellular Carcinoma Patients Treated With Nexavar and Their Distribution to Different Treatment Groups as Well as Determining Effectiveness and Safety
Clinical trial NCT01908322 · COMPLETED
Trial details
- NCT number
- NCT01908322
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-08-01
- Primary completion
- 2015-06-01
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.